Yatin Suneja
Stock Analyst at Guggenheim
(2.21)
# 2,668
Out of 4,732 analysts
109
Total ratings
44.09%
Success rate
-5.7%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRZN Surrozen | Upgrades: Buy | $45 | $12.08 | +272.52% | 3 | Jan 3, 2025 | |
| ACAD ACADIA Pharmaceuticals | Downgrades: Neutral | $20 | $17.57 | +13.83% | 6 | Jan 3, 2025 | |
| ANAB AnaptysBio | Maintains: Buy | $90 → $36 | $15.85 | +127.13% | 11 | Dec 12, 2024 | |
| QTTB Q32 Bio | Downgrades: Neutral | n/a | $3.28 | - | 2 | Dec 12, 2024 | |
| TRML Tourmaline Bio | Reiterates: Buy | n/a | $18.00 | - | 2 | Dec 11, 2024 | |
| ZBIO Zenas BioPharma | Reiterates: Buy | n/a | $7.85 | - | 2 | Dec 3, 2024 | |
| ARGX argenx SE | Maintains: Buy | $585 → $665 | $640.52 | +3.82% | 8 | Nov 1, 2024 | |
| SYRE Spyre Therapeutics | Maintains: Buy | $50 → $65 | $20.62 | +215.23% | 1 | Oct 25, 2024 | |
| VIGL Vigil Neuroscience | Maintains: Buy | $17 → $16 | $1.93 | +729.02% | 2 | Aug 14, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $155 → $170 | $70.54 | +141.00% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $180 | $143.26 | +25.65% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,180 → $1,300 | $681.58 | +90.73% | 5 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $7.66 | +317.75% | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.20 | - | 3 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $6.16 | +711.69% | 1 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $90 | $23.78 | +278.47% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $125 | $91.94 | +35.97% | 8 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $16 | $11.15 | +43.50% | 2 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $77 | $43.81 | +75.76% | 3 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $2.05 | +973.17% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $23.86 | +34.12% | 5 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $2.74 | +1,140.88% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.34 | - | 3 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $1.77 | +1,029.94% | 1 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $49 | $38.52 | +27.21% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $55 | $7.48 | +635.29% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $14 | $3.34 | +319.16% | 3 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $270 → $350 | $140.55 | +149.02% | 3 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $2.54 | - | 4 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.08 | - | 5 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $30 | $6.96 | +331.03% | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.37 | - | 3 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $17.36 | +38.25% | 1 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $34 | $51.89 | -34.48% | 2 | Jan 14, 2020 |
Surrozen
Jan 3, 2025
Upgrades: Buy
Price Target: $45
Current: $12.08
Upside: +272.52%
ACADIA Pharmaceuticals
Jan 3, 2025
Downgrades: Neutral
Price Target: $20
Current: $17.57
Upside: +13.83%
AnaptysBio
Dec 12, 2024
Maintains: Buy
Price Target: $90 → $36
Current: $15.85
Upside: +127.13%
Q32 Bio
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.28
Upside: -
Tourmaline Bio
Dec 11, 2024
Reiterates: Buy
Price Target: n/a
Current: $18.00
Upside: -
Zenas BioPharma
Dec 3, 2024
Reiterates: Buy
Price Target: n/a
Current: $7.85
Upside: -
argenx SE
Nov 1, 2024
Maintains: Buy
Price Target: $585 → $665
Current: $640.52
Upside: +3.82%
Spyre Therapeutics
Oct 25, 2024
Maintains: Buy
Price Target: $50 → $65
Current: $20.62
Upside: +215.23%
Vigil Neuroscience
Aug 14, 2024
Maintains: Buy
Price Target: $17 → $16
Current: $1.93
Upside: +729.02%
Praxis Precision Medicines
Aug 14, 2024
Maintains: Buy
Price Target: $155 → $170
Current: $70.54
Upside: +141.00%
Aug 2, 2024
Maintains: Buy
Price Target: $170 → $180
Current: $143.26
Upside: +25.65%
Aug 2, 2024
Maintains: Buy
Price Target: $1,180 → $1,300
Current: $681.58
Upside: +90.73%
Jul 23, 2024
Initiates: Buy
Price Target: $32
Current: $7.66
Upside: +317.75%
May 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.20
Upside: -
Apr 29, 2024
Initiates: Buy
Price Target: $50
Current: $6.16
Upside: +711.69%
Feb 27, 2024
Maintains: Buy
Price Target: $72 → $90
Current: $23.78
Upside: +278.47%
Feb 21, 2024
Maintains: Buy
Price Target: $110 → $125
Current: $91.94
Upside: +35.97%
Nov 15, 2023
Maintains: Buy
Price Target: $17 → $16
Current: $11.15
Upside: +43.50%
Nov 15, 2023
Maintains: Buy
Price Target: $70 → $77
Current: $43.81
Upside: +75.76%
Oct 10, 2023
Initiates: Buy
Price Target: $22
Current: $2.05
Upside: +973.17%
Sep 22, 2023
Reiterates: Buy
Price Target: $32
Current: $23.86
Upside: +34.12%
Aug 14, 2023
Reiterates: Buy
Price Target: $34
Current: $2.74
Upside: +1,140.88%
Jul 17, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.34
Upside: -
Jun 22, 2023
Initiates: Buy
Price Target: $20
Current: $1.77
Upside: +1,029.94%
Jun 15, 2023
Reiterates: Buy
Price Target: $49
Current: $38.52
Upside: +27.21%
May 18, 2023
Maintains: Buy
Price Target: $52 → $55
Current: $7.48
Upside: +635.29%
May 17, 2023
Maintains: Buy
Price Target: $12 → $14
Current: $3.34
Upside: +319.16%
May 1, 2023
Upgrades: Buy
Price Target: $270 → $350
Current: $140.55
Upside: +149.02%
Apr 6, 2023
Upgrades: Buy
Price Target: n/a
Current: $2.54
Upside: -
Jan 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $7.08
Upside: -
Nov 11, 2022
Maintains: Buy
Price Target: $42 → $30
Current: $6.96
Upside: +331.03%
Oct 14, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.37
Upside: -
May 31, 2022
Initiates: Buy
Price Target: $24
Current: $17.36
Upside: +38.25%
Jan 14, 2020
Maintains: Buy
Price Target: $29 → $34
Current: $51.89
Upside: -34.48%